|
End-of-day quote
Dhaka S.E.
2026-09-24
|
5-day change | 1st Jan Change | ||
| 17.50 BDT | -1.69% |
|
-1.69% | +29.63% |
| Market Cap | 2.27B 18.48M 16.22M 15.32M 13.96M 26.13M 1.77B 26.32M 183M 70.99M 905M 69.39M 67.89M 2.91B | P/E 2024 |
38.2x | P/E 2025 | 36x |
|---|---|---|---|---|---|
| Enterprise Value | 2.25B 18.31M 16.07M 15.17M 13.83M 25.89M 1.75B 26.07M 182M 70.33M 897M 68.74M 67.26M 2.88B | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 3.51x |
| Free-Float |
-
| Yield 2024 |
0.59% | Yield 2025 | 0.74% |
| 1 day | -1.69% | ||
| 1 week | -1.69% | ||
| Current month | +1.16% | ||
| 1 month | +2.34% | ||
| 3 months | -18.22% | ||
| 6 months | +24.11% | ||
| Current year | +29.63% |
| 1 week | 17.3 |  | 18.3 |
| 1 month | 15.8 | | 18.4 |
| Current year | 12.5 | | 23.3 |
| 1 year | 11.1 | | 23.3 |
| 3 years | 11.1 | | 24.6 |
| 5 years | 11.1 | | 35 |
| 10 years | 11.1 | | 37.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 70 | 1995-01-24 | |
| Director of Finance/CFO | - | 2017-01-31 | |
| Comptroller/Controller/Auditor | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Naim Fatema
CHM | Chairman | 72 | 2015-11-09 |
| Director/Board Member | 70 | 1995-01-24 | |
Azizur Rahman
BRD | Director/Board Member | 78 | 1995-01-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.69% | -1.69% | 0.00% | -27.08% | 14.77M | |
| +0.13% | +2.65% | +63.34% | +115.17% | 1,055B | |
| +0.20% | +0.46% | +50.92% | +70.56% | 654B | |
| -0.29% | +0.14% | +19.82% | +71.75% | 467B | |
| -0.85% | +0.98% | +42.13% | +44.64% | 348B | |
| +0.71% | +4.08% | +21.75% | +28.83% | 275B | |
| +1.23% | +0.42% | +14.11% | +12.43% | 258B | |
| +2.11% | +7.51% | +51.88% | +54.11% | 224B | |
| +0.83% | +0.55% | +34.64% | +99.83% | 187B | |
| 0.00% | -10.14% | -27.40% | -61.08% | 171B | |
| Average | +0.24% | +0.23% | +27.12% | +40.92% | 363.84B | |
| Weighted average by Cap. | +0.27% | +1.32% | +40.43% | +68.21% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 410M 3.33M 2.93M 2.76M 2.52M 4.71M 320M 4.75M 33.07M 12.81M 163M 12.52M 12.25M 525M | 432M 3.51M 3.08M 2.91M 2.65M 4.96M 336M 5M 34.79M 13.48M 172M 13.17M 12.89M 552M |
| Net income | 45.88M 373K 327K 309K 282K 527K 35.75M 531K 3.7M 1.43M 18.26M 1.4M 1.37M 58.7M | 42.65M 347K 304K 287K 262K 490K 33.23M 494K 3.44M 1.33M 16.98M 1.3M 1.27M 54.56M |
| Net Debt | -20.9M -170K -149K -141K -128K -240K -16.29M -242K -1.69M -653K -8.32M -638K -624K -26.74M | -21.27M -173K -152K -143K -131K -244K -16.57M -246K -1.72M -664K -8.47M -649K -635K -27.21M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-24 | BDT 17.50 | -1.69% | 471,682 |
| 26-09-23 | BDT 17.80 | +2.30% | 654,098 |
| 26-09-22 | BDT 17.40 | -0.57% | 384,200 |
| 26-09-21 | BDT 17.50 | -4.37% | 773,737 |
| 26-09-20 | BDT 18.30 | +2.81% | 567,750 |
- Stock Market
- Stocks
- SILCOPHL Stock
Select your edition
All financial news and data tailored to specific country editions
